Altered expression and localization of connexin32 in human and murine gastric carcinogenesis

Digestive Diseases and Sciences

Volumn 56, Issue 5, 2011, Pages 1323-1332

  Jee, Hyang ^a   Nam, Ki Taek ^b   Kwon, Hyo Jung ^c   Han, Sang Uk ^d   Kim, Dae Yong ^a  

^a Seoul National University   (South Korea)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Ajou University School of Medicine   (South Korea)

Author keywords

Cell proliferation; Connexin32; Gastric adenocarcinoma; Immunohistochemistry; Tissue array

Indexed keywords

CONNEXIN 32; KI 67 ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS;

ANIMALS; CONNEXINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 79955632979     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1467-z     Document Type: Article

References (41)

1. Loewenstein WR, Rose B. The cell-cell channel in the control of growth. Semin Cell Biol. 1992;3(1):59-79.
2. Vinken M, et al. Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology. 2008;47(3):1077-1088. (Pubitemid 351449699)
3. Alexander DB, Goldberg GS. Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem. 2003;10(19):2045- 2058. (Pubitemid 37139061)
4. Willecke K, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem. 2002;383(5):725-737. (Pubitemid 34649891)
5. Monaghan P, et al. Gap junction distribution and connexin expression in human breast. Exp Cell Res. 1996;223(1):29-38. (Pubitemid 26063919)
6. Conklin C, et al. Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer. Cancer Lett. 2007;255(2):284-294. (Pubitemid 47268644)
7. Nakashima Y, et al. Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol. 2004;39(8):763-768. (Pubitemid 39264145)
8. Kanczuga-Koda L, et al. Alterations in connexin26 expression during colorectal carcinogenesis. Oncology. 2005;68(2-3):217-222. (Pubitemid 41158979)
9. Hong R, Lim SC. Pathological significance of connexin26 expression in colorectal adenocarcinoma. Oncol Rep. 2008;19(4):913-919. (Pubitemid 351802659)
10. Inose T, et al. Correlation between connexin26 expression and poor prognosis of esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16(6):1704-1710.
11. Jamieson S, et al. Expression of gap junction proteins connexin26 and connexin43 in normal human breast and in breast tumours. J Pathol. 1998;184(1):37-43. (Pubitemid 28086151)
12. Avanzo JL, et al. Altered expression of connexins in urethane-nduced mouse lung adenomas. Life Sci. 2006;79(23):2202-2208. (Pubitemid 44646476)
13. Udaka N, Miyagi Y, Ito T. Connexin expression in mouse lung tumor. Cancer Lett. 2007;246(1-2):224-229. (Pubitemid 44959393)
14. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988;41(2):184-197.
15. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133(2):659-672. (Pubitemid 47187360)
16. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52(24):6735-6740.
17. Marshall B. Helicobacter pylori: Past, present and future. Keio J Med. 2003;52(2):80-85. (Pubitemid 36834401)
18. Fink C, et al. Specific localisation of gap junction protein connexin32 in the gastric mucosa of horses. Histochem Cell Biol. 2006;125(3):307-313. (Pubitemid 43228204)
19. Radebold K, et al. Gap junctional channels regulate acid secretion in the mammalian gastric gland. J Membr Biol. 2001;183(3):147-153. (Pubitemid 32938076)
20. Uchida Y, et al. Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans. Gastroenterology. 1995;109(5):1492-1496.
21. American Joint Committee on Cancer, A.C.S. AJCC Cancer Staging Manual. New York: Springer; 2002.
22. Han SU, et al. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol. 2002;17(3):253-261.
23. Kim B, et al. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010;42(1):58-65.
24. Madore J, et al. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma. J Pathol. 2010;220(3):392-400.
25. Grizzle WE, Myers RB, Manne U, Srivastava S, eds. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. Tumor marker protocols, Hanausek M, Walaszek Z, eds. Totowa, NJ: Human Press; 1998:143-160.
26. Mehta PP, et al. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet. 1999;24(1-2):91-110. (Pubitemid 29115552)
27. Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991;51(8):2185-2192.
28. Jinn Y, Ichioka M, Marumo F. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett. 1998;127(1-2):161-169. (Pubitemid 28230800)
29. Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: Loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991;57(2):131-135.
30. Ogawa K, et al. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Cancer Res. 1999;59(8):1830-1833. (Pubitemid 29186151)
31. Takayama T, et al. Beta-catenin expression in human cancers. Am J Pathol. 1996;148(1):39-46.
32. Xu HT, et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol. 2008;46(3):315-321.
33. Schwarz M, et al. Role of connexin32 and beta-catenin in tumor promotion in mouse liver. Toxicol Pathol. 2003;31(1):99-102. (Pubitemid 36169426)
34. Sanches DS, et al. Expression of connexins in normal and neoplastic canine bone tissue. Vet Pathol. 2009;46(5):846-859.
35. Edwards GO, et al. A quantitative inverse relationship between connexin32 expression and cell proliferation in a rat hepatoma cell line. Toxicology. 2008;253(1-3):46-52.
36. Bouzubar N, et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer. 1989;59(6):943-947. (Pubitemid 19155714)
37. Wang W, Luo H, Wang A. Expression of survivin and correlation with PCNA in osteosarcoma. J Surg Oncol. 2006;93(7):578-584. (Pubitemid 43806994)
38. Krutovskikh V, et al. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin32. Int J Cancer. 1994;56(1):87-94. (Pubitemid 24044798)
39. Vinken M, et al. Epigenetic regulation of gap junctional intercellular communication: More than a way to keep cells quiet? Biochim Biophys Acta. 2009;1795(1):53-61.
40. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006;34(20):5863-5871. (Pubitemid 44941165)
41. Cronier L, et al. Gap junctions and cancer: New functions for an old story. Antioxid Redox Signal. 2009;11(2):323-338.